Sale

Contrast Media Injectors Market

Global Contrast Media Injectors Market Size, Share, Forecast: By Product Type: Injector Systems, Consumables; By Type: Single Head Injectors, Dual-Head Injectors, Syringe less Injectors; By Applications: Radiology, Interventional Cardiology, Interventional Radiology, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Contrast Media Injectors Market Overview
 
    3.1    Global Contrast Media Injectors Market Historical Value (2017-2023) 
    3.2    Global Contrast Media Injectors Market Forecast Value (2024-2032)
4    Global Contrast Media Injectors Market Landscape
    4.1    Global Contrast Media Injectors Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Contrast Media Injectors Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Applications
5    Global Contrast Media Injectors Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Contrast Media Injectors Market Segmentation 
    6.1    Global Contrast Media Injectors Market by Product Type
        6.1.1    Market Overview
        6.1.2    Injector Systems
            6.1.2.1    CT Injector Systems
            6.1.2.2    MRI Injector Systems
            6.1.2.3    Cardiovascular/Angiography Injector Systems
        6.1.3    Consumables
            6.1.3.1    Tubing
            6.1.3.2    Syringe
            6.1.3.3    Others
    6.2    Global Contrast Media Injectors Market by Type
        6.2.1    Market Overview
        6.2.2    Single Head Injectors
        6.2.3    Dual-Head Injectors
        6.2.4    Syringe less Injectors
    6.3    Global Contrast Media Injectors Market by Applications
        6.3.1    Market Overview
        6.3.2    Radiology
        6.3.3    Interventional Cardiology
        6.3.4    Interventional Radiology
        6.3.5    Others
    6.4    Global Contrast Media Injectors Market by End User
        6.4.1    Market Overview
        6.4.2    Hospitals
        6.4.3    Diagnostics Centres
        6.4.4    Ambulatory Surgery Centres
        6.4.5    Others
    6.5    Global Contrast Media Injectors Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Contrast Media Injectors Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Contrast Media Injectors Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Contrast Media Injectors Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Contrast Media Injectors Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Contrast Media Injectors Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    General Electric
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisition
        17.1.5    Certifications
    17.2    Vivid Imaging Solutions
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisition
        17.2.5    Certifications
    17.3    Hilin Life Products, Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisition
        17.3.5    Certifications
    17.4    Jodas Expoim Pvt. Ltd.
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisition
        17.4.5    Certifications
    17.5    Lantheus
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisition
        17.5.5    Certifications
    17.6    Magnus Health
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisition
        17.6.5    Certifications
    17.7    TAEJOON PHARM
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisition
        17.7.5    Certifications
    17.8    Spago Nanomedical AB
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisition
        17.8.5    Certifications
    17.9    Guerbet
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisition
        17.9.5    Certifications
    17.10    Bracco
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisition
        17.10.5    Certifications
    17.11    Bayer AG
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisition
        17.11.5    Certifications
    17.12    Medtron AG
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisition
        17.12.5    Certifications
    17.13    NemotoKyorindo Co., Ltd.
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisition
        17.13.5    Certifications
    17.14    ulrich GmbH & Co. KG
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisition
        17.14.5    Certifications
    17.15    Sino Medical-Device Technology Co. 
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisition
        17.15.5    Certifications
18    Global Contrast Media Injectors Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of USD 1.61 billion in 2023.

The market size is anticipated to grow at a CAGR of 7.20% during the forecast period of 2024-2032 to attain a value of around USD 3.01 billion by 2032, attributable to rising number of cardiovascular diseases and cancer cases, accompanied with technological advancements and increasing investments in healthcare sector.

Major contributors to the growth of the market include the rising number of cardiovascular diseases and cancer cases, accompanied with technological advancements and increasing investments in healthcare sector.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among these regions, North America has been leading the global market and is likely to continue dominating the global market.

The different product types present in the market include injector systems and consumables. Injector systems include CT, MRI, and cardiovascular/angiography and consumables include tubing and syringe, among others.

The different types of products in the market are single head, dual-head, and syringe less injectors.

The product finds wide applications in radiology, interventional cariology, and interventional radiology, among others.

The end users of the product include hospital, diagnostic centres, and ambulatory surgery centres, among others.

Major trends that are responsible for the growth of this market are the rising number of cancer and cardiovascular diseases accompanied by technological advancements and increasing investment by governmental and healthcare bodies.

Key players involved in the market includes General Electric, Vivid Imaging Solutions, Hilin Life Products, Inc., Jodas Expoim Pvt. Ltd., Lantheus, Magnus Health, TAEJOON PHARM, Spago Nanomedical AB, Guerbet, Bracco, Bayer AG, Medtron AG, NemotoKyorindo Co., Ltd., ulrich GmbH & Co. KG, Sino Medical-Device Technology Co.

Purchase Full Report

Datasheet

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER